The solution is still usable but should be finished sooner
As recently as the onset of COVID-19 four years ago, you probably didnt know what a glucagon-like peptide 1 agonist, or GLP-1 drug, was
It's approved for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity, as an adjunct to reduced-calorie diet and increased physical activity
The standout feature for me is the reduction in constant hunger pangs, which has helped control my snacking
Future research should define composite outcomes, explore digital tools for relapse prevention, and develop adaptive pathways tailored to individual psychological profiles
Electrolyte supplementation becomes more important at higher doses, but establishing the habit now prevents problems later